Opiant Pharmaceuticals, Inc.
OPNT · NASDAQ
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $3 | -$2 | $12 | -$21 |
| Dep. & Amort. | $1 | $1 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $3 | $2 | $3 | $0 |
| Change in WC | -$5 | -$3 | -$11 | $14 |
| Other Non-Cash | $0 | $0 | -$0 | $1 |
| Operating Cash Flow | $2 | -$2 | $4 | -$1 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$0 | -$0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$15 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$15 | -$0 | -$0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $17 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $2,719 | $19 | $3 | $17 |
| Financing Cash Flow | $3 | $19 | $3 | $17 |
| Forex Effect | -$0 | -$0 | $0 | $0 |
| Net Chg. in Cash | -$10 | $17 | $6 | $16 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $48 | $31 | $25 | $8 |
| End Cash | $38 | $48 | $31 | $25 |
| Free Cash Flow | $2 | -$2 | $4 | -$1 |